RSV vaccine (GlaxoSmithKline)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for RSV vaccine (GlaxoSmithKline), covering 2013-04-29 to 2025-12-26. Get the full timeline:
Most recent: Clinical Trial Update: A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a COVID-19 mRNA Vaccine in Adults Aged 50 Years and Above [Phase 3]